Accelerating the development of priority formulations in childhood cancer  target product profiles for paediatric formulations of cyclophosphamide, etoposide, mercaptopurine, methotrexate, procarbazine, temozolomide  [electronic resource] : 

 - Geneva :  World Health Organization,  2025 
 - 1 online resource (63 pages) :  ill. 
<br/><br/><label>ISBN: </label>9789240116092 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Drug development<br/>Cancer in children--Adjuvant treatment<br/>Cancer in children
<br/><br/><label>LC Class. No.: </label>RC271 A35  / A23 2025eb